BioPharmaceutical Industry Reports
This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.
This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) subpart 12.6, quote mark Streamlined Procedures for Evaluation and Solicitation for Commercial Items, quote mark as supplemented with additional information included in this notice. This announcement and attachment constitutes the only solicitation; quotations are being requested, and a written solicitation is attached.
This solicitation is a quote mark Request for Quotation quote mark and is 100% set-aside for small business. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2005-73.
Please review the attached document, W911QY-14-T-0009, for requirement specifications, instructions to offerors, and evaluation procedures.
Jessica Ely, 301-619-8457
ACC-APG - Natick (SPS)
